Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is providing ...
OpenAI has quietly rolled out 'formatting blocks,' which tweak GPT's layout to match the UI of the task it is supposed to ...
There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback